Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Lilly’s tirzepatide beats Ozempic in head-to-head type 2 diabetes trial

pharmatimesJune 29, 2021

Tag: Lilly , Ozempic , tirzepatide , Diabetes , Nordisk

PharmaSources Customer Service